60 Degrees Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
DEFR14A: 60 Degrees Pharma Seeks Shareholder Approval for Second Reverse Stock Split, Equity Plan Boost
60 Degrees Pharmaceuticals, Inc. is calling its 2025 Annual Meeting to vote on key proposals including a potential second reverse stock split, an increase in its equity incentive plan shares, and director elections.
NASDAQ
60 Degrees Pharmaceuticals, Inc. will hold its 2025 Annual Meeting to vote on a reverse stock split, an increase in its equity incentive plan shares, and director elections, aiming to maintain Nasdaq listing and attract talent.
NASDAQ
60 Degrees Pharmaceuticals is holding a special meeting to seek stockholder approval for warrant exercises, an equity incentive plan amendment, and a reverse stock split to maintain its Nasdaq listing and enhance financial flexibility.
NASDAQ
DEF 14A: 60 Degrees Pharmaceuticals Seeks Stockholder Approval for Key Proposals at Upcoming Annual Meeting
60 Degrees Pharmaceuticals is holding its 2024 Annual Meeting of Stockholders on July 16, 2024, to vote on several proposals, including director elections, an equity incentive plan amendment, a reverse stock split, and executive option modifications.